Clinical Trial Update: T2 Heart Mapping in AMI Population for the Prediction of Short Term Major Adverse Cardiovascular Events

View source ↗

Summary

A clinical trial evaluating T2 Heart Mapping in patients with acute myocardial infarction for predicting short-term major adverse cardiovascular events has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: University of Arizona | Conditions: Myocardial Infarction, Acute | Status: WITHDRAWN